Eli Lilly & Co. (LLY)

Statement of Financial Position, Liabilities and Stockholders' Equity
Quarterly Data

Difficulty: Beginner

Annual Data

Quarterly Data

The statement of financial position provides creditors, investors, and analysts with information on company's resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company's assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Eli Lilly & Co., Consolidated Statement of Financial Position, Liabilities and Stockholders' Equity (quarterly data)

USD $ in thousands

		Mar 31, 2018		Dec 31, 2017		Sep 30, 2017		Jun 30, 2017		Mar 31, 2017		Dec 31, 2016		Sep 30, 2016		Jun 30, 2016		Mar 31, 2016		Dec 31, 2015		Sep 30, 2015		Jun 30, 2015		Mar 31, 2015		Dec 31, 2014		Sep 30, 2014		Jun 30, 2014		Mar 31, 2014		Dec 31, 2013		Sep 30, 2013		Jun 30, 2013		Mar 31, 2013
	Short-term borrowings and current maturities of long-term debt
	Accounts payable
	Employee compensation
	Sales rebates and discounts
	Dividends payable
	Income taxes payable
	Deferred income taxes
	Other current liabilities
	Current liabilities
	Long-term debt, excluding current maturities
	Accrued retirement benefits
	Long-term income taxes payable
	Other noncurrent liabilities
	Other liabilities
	Total liabilities
	Common stock
	Additional paid-in capital
	Retained earnings
	Employee benefit trust
	Accumulated other comprehensive loss
	Cost of common stock in treasury
	Total Eli Lilly and Company shareholders' equity
	Noncontrolling interests
	Total equity
	Total liabilities and equity

Source: Eli Lilly & Co., Quarterly and Annual Reports

Item	Description	The company
Accounts payable	Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).	Eli Lilly & Co.'s accounts payable increased from Q3 2017 to Q4 2017 but then slightly declined from Q4 2017 to Q1 2018 not reaching Q3 2017 level.
Current liabilities	Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.	Eli Lilly & Co.'s current liabilities increased from Q3 2017 to Q4 2017 but then declined significantly from Q4 2017 to Q1 2018.
Other liabilities	Total obligations incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle.	Eli Lilly & Co.'s other liabilities increased from Q3 2017 to Q4 2017 but then slightly declined from Q4 2017 to Q1 2018.
Total liabilities	Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.	Eli Lilly & Co.'s total liabilities increased from Q3 2017 to Q4 2017 but then slightly declined from Q4 2017 to Q1 2018 not reaching Q3 2017 level.
Total Eli Lilly and Company shareholders' equity	Total of all Stockholders' Equity (deficit) items, net of receivables from officers, directors owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest).	Eli Lilly & Co.'s total Eli Lilly and Company shareholders' equity declined from Q3 2017 to Q4 2017 but then increased from Q4 2017 to Q1 2018 not reaching Q3 2017 level.
Total equity	Total of Stockholders' Equity (deficit) items, net of receivables from officers, directors owners, and affiliates of the entity including portions attributable to both the parent and noncontrolling interests (previously referred to as minority interest), if any. The entity including portions attributable to the parent and noncontrolling interests is sometimes referred to as the economic entity.	Eli Lilly & Co.'s total equity declined from Q3 2017 to Q4 2017 but then increased from Q4 2017 to Q1 2018 not reaching Q3 2017 level.

	Eli Lilly & Co.	Other companies (not purchased previously)
Financial Statements
Common-Size Financial Statements
Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis
Financial Reporting Quality

	All companies
Financial Statements
Common-Size Financial Statements
Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis
Financial Reporting Quality

Eli Lilly & Co. (LLY)

Statement of Financial Position, Liabilities and Stockholders' EquityQuarterly Data

Statement of Financial Position, Liabilities and Stockholders' Equity
Quarterly Data